Results
1
These companies have already demonstrated past earnings growth, and analysts are forecasting further income growth. We've excluded mining and oil stocks because they are very cyclical.
1 companies
argenx
Market Cap: €38.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€630.60
7D
-2.9%
1Y
18.7%